Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ETCompany ParticipantsAJ Schwabe - Corporate ParticipantBruce C.

Delivers Category Leading GrowthDrives Operational Efficiencies that Deliver Margin Expansion and Reduce Capital ...

Study conducted in collaboration with TSC Alliance using a well-accepted Tsc1-knockout model First clinical study for simufilam in TSC-related epilepsy expected to begin in H1 2026 AUSTIN, Texas, Aug.

FRIENDSWOOD, Texas, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its ...

PITTSBURGH, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today reported financial results for the second quarter ending June 30, 2025 and provided a business ...